It was in 1992 that Discovery Laboratories was founded as a specialty biotechology company. The business is focused on the development of novelty products for respiratory critical care. The company is one of the major alliances of Laboratorios del Dr. Esteve, S. A.
This American company is based in Warrington, Pennsylvania and continues to develop and commercialize products for patients with respiratory diseases. Their two main offerings are Surfaxin and Aerosurf. The latter is a drug-device that helps prevent respiratory distress syndrome (RDS) in premature infants while the former is synthetic, peptide-containing (KL4) surfactant. This product is similar to natural pulmonary surfactant which is contained in the lungs to ensure proper respiratory functions.
The offerings of the company are created to address the deficiency of surfactants in the patient’s lungs or to address is improper functions. By developing these medications, the company is able to address pulmonary diseases like RDS and acute lung injury, among other respiratory conditions.
No comments:
Post a Comment